Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075684 · ClinicalTrials.gov registry record · NA
Office-based Percutaneous Ultrasound-guided Renal Biopsy
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02075684 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 60 participants.
The verdict
NCT02075684, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research study is to create a prospectively maintained, multicenter database of patients undergoing renal biopsy for renal masses performed percutaneously (through skin), via an 18 gauge biopsy needle (.048 inches). In this database, the investigators will collect and maintain the data from the biopsy procedure. This will allow us to evaluate our experience with this procedure as well as to participate in multi-institutional collaborative studies in the future. At University of California Irvine, the investigators routinely biopsy patients with renal masses under real-time ultrasound control. Percutaneous renal biopsy under ultrasound guidance is a routine procedure performed to diagnose renal mass histopathology. The safety and efficacy of this procedure has been well documented in the literature. The indications for percutaneous renal biopsy have expanded as there has been a substantial increase in the number of renal masses that are being diagnosed, and the acceptance of percutaneous biopsy continues to expand in parallel. The biopsy procedure is part of your normal standard of care and if not being done for this research project.
Interventions
- PROCEDURE Renal Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-04-01 |
| Est. Completion | 2024-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02075684
The ClinicalTrials.gov registry entry for NCT02075684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renal Biopsy is the first listed.
NCT02075684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02075684 about?
NCT02075684 is a clinical study titled "Office-based Percutaneous Ultrasound-guided Renal Biopsy". The purpose of this research study is to create a prospectively maintained, multicenter database of patients undergoing renal biopsy for renal masses performed percutaneously (through skin), via an 18 gauge biopsy needle (.048 inches). In this database, the investigators will collect and maintain th...
What is the current status of trial NCT02075684?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-04-01. Estimated completion is 2024-04.
What interventions are being tested in trial NCT02075684?
The interventions under investigation include: Renal Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02075684?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.